Prof of International Maternal Health at University of Liverpool and consultant obstetrician. Based at the Sanyu Unit, specialises in low cost technologies.
Why is UK maternity care in crisis with a caesarean section rate of over 40%? We show how multiple, well intentioned changes have come to together to create the perfect storm...
https://t.co/z1f3qwH4dm
@RCObsGyn@NHSEngland@wesstreeting@livuninews@BICSoc@LiverpoolWomens
What do women living in rural Uganda see as the priorities for reproductive health? Some of their answers may surprise you! See the results in The Lancet Obstetrics, Gynaecology, & Women’s Health https://t.co/5XGhpVLzZa @EDCTP@NIHRresearch@BusitemaUni@LivUni@LindAlliance
I'm proud that the PPH Butterfly is included in this exhibition at the University of Liverpool on 'Lightbulb Moments'. Come and visit! Its open from 11th September. @PPHbutterfly@NIHRresearch@WHO https://t.co/eX42oiDA5S
Looking forward to taking part in this webinar tomorrow. Join us for this free webinar - and join the PPH CoP.
PPH CoP Webinar: Preventing PPH Mortality Globally — How Are We Doing? https://t.co/VJ2e0EksPH
🌍 Call for Experts!
HRP is seeking professionals with experience in SRHR in humanitarian settings to align SRH interventions in the MISP & H3 Framework.
🗓️ Apply by 30 January 2025.
📧 Details: https://t.co/FJv9lK8p1e
#SRHR
La Reina ha entregado el “XIX premio Dexeus Mujer” al profesor Arri Coomarasamy de la Universidad de Birmingham (Reino Unido), en reconocimiento a su contribución para prevenir las pérdidas gestacionales y reducir la mortalidad materna durante el parto.
➡️https://t.co/xASlDaQE80
We are recruiting sites for the @NIHRresearch funded GILD trial led by @kate3539 & @eleanor_mitch
If you’re a hospital who sees women with #gestationaldiabetes & want to contribute to a study looking at intrapartum blood glucose monitoring let us know!
https://t.co/ZpA7c3pa7S
Misoprostol as Oral Solution or Oral Tablet for Induction of Labour (MISOBEST): A Randomised Controlled Non-Inferiority by researchers at @karolinskainst
https://t.co/EZu1yVCPpT
It was truly an honour for me to give the keynote address at the AXA European Works Council (@axa_ewc) earlier today in Paris. I was thrilled by the enthusiasm of thr audience on issues of access to critical #maternity care in #Africa. "Being a woman shouldn't be a risk!"#AXAEWC
Misoprostol as Oral Solution or Oral Tablet for Induction of Labour (MISOBEST): A Randomised Controlled Non-Inferiority by researchers at @karolinskainst
https://t.co/EZu1yVChAl
BirthGlide Ltd is a medical device co. with a mission to make childbirth safer for mothers & babies. To help with their development process, they hope to gather valuable input from mothers. Please complete the survey👉https://t.co/OoMJVvOEBS
@LiverpoolWomens@adweeks@BirthTrauma